Cargando…
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
[Image: see text] Immunotherapy provides the best approach to reduce the high mortality of metastatic breast cancer (BC). We demonstrate a chemo-immunotherapy approach, which utilizes a liposomal carrier to simultaneously trigger immunogenic cell death (ICD) as well as interfere in the regionally ov...
Autores principales: | Lu, Jianqin, Liu, Xiangsheng, Liao, Yu-Pei, Wang, Xiang, Ahmed, Ayman, Jiang, Wen, Ji, Ying, Meng, Huan, Nel, Andre E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262474/ https://www.ncbi.nlm.nih.gov/pubmed/30481959 http://dx.doi.org/10.1021/acsnano.8b05189 |
Ejemplares similares
-
Retraction
of “Breast Cancer Chemo-immunotherapy
through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus
Interference in the IDO-1 Pathway”
por: Lu, Jianqin, et al.
Publicado: (2021) -
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
por: Liu, Xiangsheng, et al.
Publicado: (2021) -
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
por: Lu, Jianqin, et al.
Publicado: (2017) -
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
por: Shi, Xiaowei, et al.
Publicado: (2023) -
Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by Nanocarriers
por: Chattopadhyay, Saborni, et al.
Publicado: (2023)